The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nicorette Invisi Extra Strength 25 mg/16 hours transdermal patch

PCO Manufacturing Ltd.PPA0465/187/009

Main Information

Trade NameNicorette Invisi Extra Strength 25 mg/16 hours transdermal patch
Active SubstancesNicotine
Dosage FormTransdermal patch
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/187/009

Group Information

ATC CodeN07BA Drugs used in nicotine dependence
N07BA01 nicotine


License statusAuthorised
Licence Issued05/08/2022
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceIn general sale outlets can only be sold or supplied to adults aged 18 years or above. Product not subject to medical prescription for a maximum daily dose of 22 mg expressed as the dose delivered over a 24-hour period
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back